Clinical Trials Logo

Clinical Trial Details — Status: Not yet recruiting

Administrative data

NCT number NCT06118437
Other study ID # XJLL-KY-20232231
Secondary ID
Status Not yet recruiting
Phase
First received
Last updated
Start date November 15, 2023
Est. completion date May 31, 2025

Study information

Verified date November 2023
Source Air Force Military Medical University, China
Contact Yang lin Pan, MD
Phone 862984771536
Email yanglinpan@hotmail.com
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

Gastrointestinal tumors (esophageal cancer, gastric cancer, colorectal cancer) seriously threaten human health, with a high incidence rate and cancer related hope mortality. Digestive endoscopy is the main method for screening gastrointestinal tumors. Early screening of gastrointestinal tumors can improve the detection of early cancer and improve prognosis. The five-year survival rate of early stage tumors after comprehensive treatment can reach 90%, while the five-year survival rate of late stage tumors is less than 30%. Therefore, the screening of gastrointestinal tumors is very important. Studies have shown that there are similarities in risk factors for gastrointestinal tumors, such as age, gender, family history, smoking, alcohol consumption, etc. Currently, established digestive malignancies are targeted at a single malignant tumor. At present, there is a lack of understanding of the overall risk factors associated with gastrointestinal tumors and the establishment of relevant risk prediction models. Therefore, we conducted a prospective, multicenter cross-sectional study to explore the independent risk factors of combined gastrointestinal tumors and establish a risk prediction model for combined screening of gastrointestinal tumors.


Recruitment information / eligibility

Status Not yet recruiting
Enrollment 6250
Est. completion date May 31, 2025
Est. primary completion date December 31, 2024
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group 18 Years to 80 Years
Eligibility Inclusion Criteria: - Individuals aged 18-80 who undergo both gastroscopy and colonoscopy simultaneously Exclusion Criteria: - (1)Previously diagnosed with esophageal, gastric, or colorectal cancer; (2) Suspected presence of gastrointestinal obstruction or perforation; (3) Previous history of esophageal, gastric, or colorectal surgery; (4) Those who are not suitable for endoscopic examination due to serious diseases or unstable hemodynamics; (5) Individuals who are unable to obtain relevant information due to communication barriers such as mental or neurological disorders; (6) Pregnancy or lactation period; (7) Not willing or unable to sign the informed consent form.

Study Design


Related Conditions & MeSH terms


Locations

Country Name City State
China Xijing of Digestive Diseases Xi'an Shaanxi

Sponsors (1)

Lead Sponsor Collaborator
Air Force Military Medical University, China

Country where clinical trial is conducted

China, 

References & Publications (2)

Klein EA, Richards D, Cohn A, Tummala M, Lapham R, Cosgrove D, Chung G, Clement J, Gao J, Hunkapiller N, Jamshidi A, Kurtzman KN, Seiden MV, Swanton C, Liu MC. Clinical validation of a targeted methylation-based multi-cancer early detection test using an independent validation set. Ann Oncol. 2021 Sep;32(9):1167-1177. doi: 10.1016/j.annonc.2021.05.806. Epub 2021 Jun 24. — View Citation

Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, Bray F. Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. CA Cancer J Clin. 2021 May;71(3):209-249. doi: 10.3322/caac.21660. Epub 2021 Feb 4. — View Citation

Outcome

Type Measure Description Time frame Safety issue
Primary Overall detection rate of gastrointestinal cancer The proportion of at least one type of gastrointestinal malignant tumor detected 2 years
See also
  Status Clinical Trial Phase
Active, not recruiting NCT05014477 - Therapy Strategies After LAA Occluder Device Embolization
Active, not recruiting NCT05909592 - Shoulder Injury Rate and Risk Among CrossFit Participants in Greece. Εfficacy of an Innovative Prevention Program.
Recruiting NCT02905552 - Myelodysplasic Syndromes and Risk Factors for Infection N/A
Recruiting NCT05788861 - Invasive Group A Streptococcal Infection
Completed NCT04619511 - Risk Factors for Post-ESWL and Post-ERCP Pancreatitis
Completed NCT05389540 - Rural South and Southeast Asia Household Health Survey
Not yet recruiting NCT05564975 - Construction and Application of Pressure Injury Risk Prediction Model for Critically Ill Patients
Not yet recruiting NCT05519657 - Incidence and Risk Factors of PPCs in Elderly Patients Undergoing Robot Assisted Laparoscopic Pelvic Surgery
Recruiting NCT04912739 - Targeted Health Dialogues in Primary Care
Completed NCT05535309 - Establishment of Risk Factors Model of Drug-induced Coagulation Disorder Caused by Cefoperazone Sulbactam Sodium
Recruiting NCT03713931 - PUMA Implementation 2
Recruiting NCT06441240 - Evaluation of Recurrence Risk Factors in Locally Advanced Breast Cancer Patients Underwent Neoadjuvant Chemotherapy.
Completed NCT00699725 - Adherence to Gastro-protection in Non-steroidal Anti-inflammatory Drug (NSAID) Using Patients N/A
Completed NCT00888030 - P-cresol: Correlation With Glomerular Filtration Rate and Outcome in Chronic Kidney Disease N/A
Not yet recruiting NCT06288724 - MOdifiable facTors to Improve VentilAtion ThErapy in ICU
Recruiting NCT06374849 - Intraoperative Sufentanil and Chronic Postsurgical Pain in Non-major Scheduled Abdominal Surgery Phase 4
Completed NCT04683380 - Robustness Predictive Factors in People Aged Over 75 Years After Going to the Emergency Room (ROB-U)
Completed NCT02884167 - Multidimensional Risk Factor Assessment in Constipation N/A
Not yet recruiting NCT05473403 - Validation of a Prognostic Score for Steroid Therapy Response in Acute Severe Autoimmune Hepatitis N/A
Completed NCT06411496 - Creation, Implementation and Validation of Intra- and Postoperative Risk Prediction Models